BioCryst Reports Second Quarter 2026 Financial Results
Go back to BioCryst Reports Second Quarter 2026 Financial Results| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.44 -0.13 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.57 | 52 Week High | $10.98 | |||
| Open | $8.54 | 52 Week Low | $1.63 | |||
| Day High | $8.65 | P/E | N/A | |||
| Day Low | $8.40 | EPS | $-0.68 | |||
| Volume | 2,828,885 | |||||

